A brain MRI ordered “with and without contrast” gives your doctor two different views of your brain in a single session. The non-contrast images capture the brain’s natural anatomy and can reveal structural abnormalities, bleeding, or tissue changes on their own. The contrast-enhanced images, taken after a gadolinium-based dye is injected into your vein, highlight areas where the brain’s protective barrier has broken down or where blood vessels are behaving abnormally. Ordering both together lets radiologists compare the two sets of images side by side, which is often the only reliable way to distinguish between conditions that look similar on just one type of scan.
What Contrast Actually Does Inside Your Brain
The contrast agent used in brain MRIs is a gadolinium-based compound, not the iodine-based dye used in CT scans. Gadolinium is a metal that interacts magnetically with the water molecules in your tissues, changing how they behave under the MRI scanner’s magnetic field. The result is that areas where gadolinium accumulates appear brighter on certain image sequences, making them stand out from surrounding tissue.1Oxford Academic. The biological fate of gadolinium-based MRI contrast agents: a call to action for bioinorganic chemists
Here is the critical detail: gadolinium does not cross an intact blood-brain barrier. Your brain has a tightly sealed network of blood vessels that keeps most circulating substances out of brain tissue. When those vessels are healthy, the contrast agent stays inside them and washes out through your kidneys. But when something damages the barrier, such as a tumor, infection, or inflammation, the contrast leaks through and pools in the affected tissue, lighting it up on the scan.2Frontiers in Aging Neuroscience. Imaging blood-brain barrier dysfunction: A state-of-the-art review from a clinical perspective That leakage pattern is itself a diagnostic clue. The shape, location, and intensity of contrast enhancement all tell the radiologist different things about what is going on.
Why You Need the Non-Contrast Images Too
If contrast is so useful, you might wonder why the scan doesn’t just use it from the start. The non-contrast portion of the exam is not filler. Several important findings show up only, or show up best, without contrast. Fresh bleeding, for instance, has a distinctive appearance on unenhanced images that contrast can actually obscure. Calcifications, certain types of cysts, and the natural signal differences between gray matter and white matter are all easier to evaluate before contrast is introduced.
The non-contrast images also serve as a baseline. When the radiologist compares the pre-contrast and post-contrast scans, any new bright spots on the post-contrast images are definitively caused by contrast enhancement, not by something that was already bright on its own. Without that comparison, a naturally bright area on a scan could be mistaken for active disease, or real enhancement could be dismissed as a pre-existing finding. The side-by-side comparison is what makes the exam so much more informative than either scan alone.
Tumors and Masses
Brain tumors are one of the most common reasons a doctor orders the combined exam. The non-contrast images reveal the tumor’s size, shape, and effect on surrounding structures, such as whether it is pushing brain tissue aside or causing swelling. Contrast then shows how aggressively the tumor recruits blood vessels and whether those vessels are leaky, which tends to correlate with how fast-growing or malignant the tumor is. A low-grade glioma might show little or no enhancement, while a high-grade glioblastoma typically lights up intensely in a ring pattern. That distinction matters enormously for treatment planning.
Metastatic tumors, where cancer from elsewhere in the body has spread to the brain, are another major reason. These secondary tumors are sometimes small enough that they would be invisible on non-contrast images alone. Because metastatic deposits almost always disrupt the blood-brain barrier, contrast enhancement picks them up with high reliability. If your doctor suspects cancer has spread, the combined scan is the standard approach.
Multiple Sclerosis and Other Inflammatory Conditions
In multiple sclerosis, the immune system attacks the protective covering of nerve fibers, creating patches of damage called lesions scattered throughout the brain. Non-contrast MRI can show these lesions clearly and is the backbone of MS diagnosis. But contrast adds a time dimension: a lesion that enhances with gadolinium is actively inflamed right now, while one that does not enhance is older or no longer active. This distinction between active and inactive lesions drives treatment decisions, because new enhancement suggests the disease is breaking through whatever medication a patient is on.
The comparison gets more nuanced in long-standing MS. Some older lesions develop a rim of iron-laden immune cells that can mimic the appearance of contrast enhancement on certain sequences. A consensus statement on imaging these so-called paramagnetic rim lesions recommends confirming that the lesion does not actually enhance with gadolinium before labeling it as a chronic active lesion.3Brain. Imaging chronic active lesions in multiple sclerosis: a consensus statement Without the contrast portion of the exam, that distinction would be impossible to make.
Infections of the Brain and Its Coverings
When doctors suspect meningitis, encephalitis, or a brain abscess, contrast-enhanced MRI is often essential. The membranes covering the brain, called the meninges, normally do not enhance very much. In bacterial or fungal meningitis, however, they light up intensely and in characteristic patterns that help narrow down the type of infection.4PubMed Central. Neuroimaging Patterns of Intracranial Infections: Meningitis, Cerebritis, and Their Complications
Brain abscesses present a particular diagnostic challenge because they can look like tumors on non-contrast images. Both appear as round masses with surrounding swelling. Contrast helps because an abscess typically shows a smooth, thin ring of enhancement, while a tumor often has a thicker, more irregular enhancing rim. Combining that contrast pattern with other MRI techniques can help radiologists tell the two apart and avoid unnecessary surgery.5Neuroimaging Clinics of North America. ENCEPHALITIS, CEREBRITIS, AND BRAIN ABSCESS: Pathophysiology and Imaging Findings
Blood Vessel Problems
Contrast-enhanced MRI can also evaluate the walls of the brain’s blood vessels directly, a technique called vessel wall imaging. In conditions like cerebral vasculitis, where the blood vessel walls become inflamed, the walls themselves enhance with gadolinium, showing up as bright rings on the scan.6PLOS ONE. High-resolution contrast-enhanced vessel wall imaging in patients with suspected cerebral vasculitis This is valuable because vasculitis can cause strokes, and catching it early changes treatment from blood thinners to immune-suppressing drugs.
In patients who have had a stroke of unknown cause, vessel wall imaging with contrast has shown concentric enhancement of artery walls across multiple brain regions, pointing toward vasculitis as the culprit when other tests come back normal.7PubMed. Intracranial Vessel Wall MRI in Cryptogenic Stroke and Intracranial Vasculitis Without the contrast portion, these inflamed vessel walls would look perfectly normal on the scan.
Monitoring After Brain Tumor Treatment
If you have already been treated for a brain tumor, your follow-up MRIs will almost certainly be ordered with and without contrast, and the stakes of the comparison are high. After radiation therapy, the treated area often develops changes that look exactly like a returning tumor on standard imaging: new enhancement, growing bright spots, increasing swelling. This phenomenon, called radiation necrosis, is dead tissue from the treatment itself, not cancer regrowth. Getting the two confused can lead to unnecessary second surgeries or, conversely, false reassurance that a true recurrence is just treatment effect.
Perfusion MRI, which tracks how contrast flows through tissue over time, helps make this distinction. Tumor recurrence tends to have high blood volume because cancer aggressively builds new vessels, while radiation necrosis does not. Research combining contrast-based perfusion data with other imaging techniques has achieved very high accuracy in distinguishing between the two.8PubMed Central. Role of FDG-PET/MRI, FDG-PET/CT, and Dynamic Susceptibility Contrast Perfusion MRI in Differentiating Radiation Necrosis from Tumor Recurrence in Glioblastomas 9The Egyptian Journal of Radiology and Nuclear Medicine. Recurrent brain tumor versus radiation necrosis; can dynamic susceptibility contrast (DSC) perfusion magnetic resonance imaging differentiate? This is one of the scenarios where the combined exam is not just preferred but genuinely necessary.
Pituitary Gland Imaging
The pituitary gland sits at the base of the brain and is a common site for small benign tumors called microadenomas. These are typically found during workups for hormonal problems. Pituitary MRIs use a special rapid-contrast technique called dynamic imaging, where scans are taken in quick succession as the contrast first arrives, because microadenomas enhance more slowly than normal pituitary tissue. That brief window of differential enhancement is often the only way to see them.
Research comparing different sequences found that post-contrast imaging detected about 89% of microadenomas, compared with roughly 71% on one type of non-contrast sequence and 56% on another.10PubMed Central. Rethinking MRI Protocols for Pituitary Microadenomas: Prioritizing Non-Contrast Imaging for Safe Follow-Up For initial diagnosis, contrast clearly wins. But the same study noted that microadenomas tend to stay the same size over time, which has prompted some researchers to suggest that follow-up scans for known, stable microadenomas could potentially skip the contrast and rely on non-contrast sequences. For the first scan, though, contrast remains the standard.
Safety Concerns With Gadolinium
Gadolinium contrast is broadly considered safe, but it is not risk-free, which is part of why doctors do not order contrast on every MRI. The most immediate concern is an allergic-type reaction. Adverse events at standard clinical doses occur in roughly 0.07% to 2.4% of patients, with true hypersensitivity reactions being rarer still, in the range of 0.004% to 0.7%.11PubMed Central. Hypersensitivity to Gadolinium-Based Contrast Media Most of these are mild, like hives or nausea, though severe anaphylactic reactions can occur in rare cases. If you have had a previous reaction to gadolinium, your doctor will weigh the risk carefully and may premedicate you with antihistamines and steroids, or choose a different contrast agent.
The more serious historical concern involves kidney function. In patients with severely reduced kidney function, certain older gadolinium formulations were linked to a condition called nephrogenic systemic fibrosis, a serious disease causing thickening and hardening of the skin and connective tissues. This led to widespread kidney-function screening before contrast MRIs. However, newer gadolinium agents have dramatically reduced this risk. A systematic review of patients with advanced kidney disease receiving newer-generation agents found zero cases of the condition across nearly 5,000 patients.12JAMA Internal Medicine. Risk of Nephrogenic Systemic Fibrosis in Patients With Stage 4 or 5 Chronic Kidney Disease Receiving a Group II Gadolinium-Based Contrast Agent Screening is still standard practice, though, because the older agents have not entirely disappeared and the consequences of getting it wrong are severe.13PubMed Central. Gadolinium-Based Contrast Agents in Kidney Disease: A Comprehensive Review and Clinical Practice Guideline Issued by the Canadian Association of Radiologists
Gadolinium Staying in the Brain
A discovery that surprised the radiology community came in the mid-2010s: gadolinium can deposit in certain parts of the brain after repeated contrast MRIs, showing up as bright spots on later unenhanced scans, particularly in the deep brain structures called the dentate nucleus and globus pallidus.14PubMed Central. Gadolinium Deposition in Brain: Current Scientific Evidence and Future Perspectives The amount of deposition appears to increase with the number of contrast doses a person has received over their lifetime.
The critical question, whether this retained gadolinium actually harms anyone, remains unanswered. No studies in humans or animals have demonstrated adverse clinical effects from brain gadolinium deposits.15The Lancet Neurology. Recommendations for the use of gadolinium-based contrast agents That said, the uncertainty has changed clinical practice. Radiologists now think more carefully about whether contrast is truly necessary for each scan, particularly in patients who will need many MRIs over their lifetime, like those with MS or brain tumors under surveillance. When a non-contrast scan can answer the clinical question, most radiologists will skip the gadolinium. The “with and without” order reflects a judgment that contrast is genuinely needed for that particular patient and that particular question.
Pregnancy and Gadolinium
Pregnant women present a unique dilemma. MRI itself, without contrast, is considered safe during pregnancy because it does not use radiation. Gadolinium is a different matter. The contrast agent crosses the placenta, and its safety for the developing fetus has not been definitively established. Current recommendations generally discourage gadolinium use during pregnancy unless the diagnostic information is critical for the mother’s health and cannot be obtained any other way.16PubMed Central. Safety of gadolinium during pregnancy
In practice, this means that if a pregnant patient needs a brain MRI for something like a new seizure or sudden vision loss, the scan will typically be done without contrast first. Only if the non-contrast images leave a dangerous question unanswered, and no alternative imaging strategy can fill the gap, would contrast be added.17PubMed. Neuroimaging safety during pregnancy and lactation: a review For breastfeeding mothers, the concern is lower because very little gadolinium enters breast milk, and even less is absorbed through the infant’s gut, but some doctors still recommend pumping and discarding milk for 24 hours after the exam as a precaution.
Contrast-Free Alternatives on the Horizon
Researchers are actively working on MRI techniques that could provide some of the information contrast gives without injecting anything. The most promising is arterial spin labeling, which uses radiofrequency pulses to magnetically “tag” the blood already flowing through your body and track where it goes. It measures blood flow and perfusion without any external agent.
Early results in brain tumor surveillance suggest that arterial spin labeling has roughly the same diagnostic accuracy as contrast-based perfusion techniques for distinguishing tumor types and monitoring for recurrence.18PubMed Central. Diagnostic Accuracy of Arterial Spin Labeling in Comparison With Dynamic Susceptibility Contrast-Enhanced Perfusion for Brain Tumor Surveillance at 3T MRI In stroke imaging, it has shown reasonable sensitivity for identifying the mismatch patterns that guide treatment decisions, though its accuracy is not yet on par with contrast-based methods.19PubMed Central. Role of Magnetic Resonance Perfusion Imaging in Acute Stroke: Arterial Spin Labeling Versus Dynamic Susceptibility Contrast-Enhanced Perfusion
These techniques are promising but not yet ready to replace gadolinium across the board. They work well for measuring blood flow but cannot replicate the specific information that blood-brain barrier breakdown provides, which is the bread and butter of contrast-enhanced brain MRI. For now, arterial spin labeling is best suited as a complement to contrast imaging or as an alternative for patients who cannot safely receive gadolinium.
What the Order Actually Means for Your Appointment
If you are scheduled for a brain MRI “with and without contrast,” expect the appointment to last roughly 45 minutes to an hour, sometimes longer. You will lie in the scanner for the non-contrast portion first, which involves several different image sequences and takes 15 to 25 minutes. Then the technologist will slide you partway out, place an IV line if one is not already in, inject the gadolinium, and slide you back in for the contrast-enhanced sequences. The whole process happens in one session, on the same machine, without you needing to change position significantly.
You will likely be asked about kidney problems, allergies, and whether you could be pregnant before the exam. If your kidney function is uncertain, a blood test measuring your estimated glomerular filtration rate may be ordered in advance. The contrast injection itself feels like a brief cool sensation in the arm, and some people notice a metallic taste for a minute or two. Side effects beyond that are uncommon.
The combined exam does cost more than a non-contrast MRI alone, largely because of the gadolinium agent itself and the additional imaging time. Insurance typically covers it when the ordering physician documents a clinical indication that justifies contrast, such as a suspected tumor, known MS, or post-surgical surveillance. If you are asked to get prior authorization, the justification usually needs to align with established appropriateness criteria that radiology societies have published for various clinical scenarios.
When Your Doctor Might Choose Only One
Not every brain MRI needs both. A scan ordered to evaluate chronic headaches with no red-flag symptoms, for example, is often done without contrast, because the main goal is ruling out structural abnormalities that non-contrast images handle well. A scan ordered specifically to check whether a known brain tumor is responding to chemotherapy might be done with contrast only, since the enhancement pattern is the primary question and baseline non-contrast anatomy was established on a prior exam.
The “with and without” order is reserved for situations where the comparison between the two datasets is diagnostically important, where the doctor needs to see both the brain’s native tissue characteristics and the pattern of barrier breakdown or abnormal vascularity. In practice, this covers a wide range of clinical scenarios: first-time evaluation of a suspected mass, workup for new neurological symptoms of unclear cause, assessment of suspected infection, initial staging of known cancer for brain involvement, and monitoring of inflammatory diseases like MS. If your doctor has ordered the combined exam, they have concluded that contrast will likely add meaningful information to your care and that the small risks are outweighed by the diagnostic value.